Aviso: Este site agrega dados públicos oficiais da FDA, ClinicalTrials.gov, PubMed e SEC EDGAR apenas para referência geral. Não constitui aconselhamento médico, diagnóstico, recomendação de tratamento ou aconselhamento de investimento.

PubMed

Three-Dimensional Printing: A Catalyst for a Changing Orthopaedic Landscape.

PMID: 32224627 · 2020

J, o, n, a, t, h, a, n, , M, i, n, t, o, ;, , X, u, a, n, , Z, h, o, u, ;, , J, e, n, n, a, , O, s, b, o, r, n, ;, , L, i, j, i, e, , G, r, a, c, e, , Z, h, a, n, g, ;, , K, a, u, s, i, k, , S, a, r, k, a, r, ;, , R, a, j, , D, , R, a, o

RevistaJBJS reviews
Ano2020
PMID32224627

Resumo

Three-dimensional (3D) printing is an emerging tool in provider and patient education, surgical planning, and the design and implementation of medical devices and implants. Recent decreases in the cost of 3D printers along with advances in and cost reduction of printable materials have elevated 3D printing within the medical device industry. The advantages of 3D printing over traditional means of implant manufacturing lie in its ability to use a wide array of materials, its fine control of the m

Fonte oficial

Ver no PubMed →

Dados provenientes do PubMed / NCBI. Para consultar o texto integral e as informações mais recentes, recorra sempre ao registo oficial.

↑